Byun Seok-Soo, Hwang Eu Chang, Kang Seok Ho, Hong Sung-Hoo, Chung Jinsoo, Kwon Tae Gyun, Kim Hyeon Hoe, Kwak Cheol, Kim Yong-June, Lee Won Ki
Department of Urology, College of Medicine, Seoul National University, Seoul, Korea.
Department of Urology, College of Medicine, Chonnam National University, Gwangju, Korea.
Clin Genitourin Cancer. 2017 Sep 6. doi: 10.1016/j.clgc.2017.08.015.
We assessed the prognostic significance of obesity in relation to sex in patients with nonmetastatic clear-cell renal-cell carcinoma (nm-cRCC) in a large multicenter setting in Korea.
A total of 2097 patients with nm-cRCC who underwent surgery with curative intent were enrolled from 6 institutions in Korea between April 2000 and February 2014. Obesity was determined by body mass index (BMI) before surgery. BMI was used as a continuous variable and was categorized as normal (≥ 18.5 to < 25.0 kg/m, normal BMI) and overweight or obese (≥ 25 kg/m, high BMI). The relationships between BMI, sex, recurrence-free survival (RFS), and cancer-specific survival (CSS) were evaluated.
Male patients had a greater high BMI ratio than female patients (P = .030). In men, the 5-year RFS and CSS rates in the high BMI group were greater than those in the normal BMI group (P = .003 and .006, respectively). Multivariate analyses revealed that in men, a high BMI was associated with greater RFS or CSS rates (hazard ratio: RFS, 0.901, P = .001; CSS, 0.822, P < .001). In women, there were no significant differences in the 5-year RFS and CSS rates according to BMI (P = .531 and .323, respectively), and high BMI was not associated with RFS or CSS (P = .250 and .180, respectively).
In patients with nm-cRCC, obesity was a favorable prognosticator in male but not female patients. Therefore, the association between obesity and nm-cRCC prognosis might differ by sex.
我们在韩国一个大型多中心研究中评估了肥胖在非转移性透明细胞肾细胞癌(nm-cRCC)患者中与性别相关的预后意义。
2000年4月至2014年2月期间,从韩国6家机构招募了总共2097例接受根治性手术的nm-cRCC患者。肥胖通过术前体重指数(BMI)确定。BMI作为连续变量,分为正常(≥18.5至<25.0 kg/m,正常BMI)和超重或肥胖(≥25 kg/m,高BMI)。评估了BMI、性别、无复发生存期(RFS)和癌症特异性生存期(CSS)之间的关系。
男性患者的高BMI比例高于女性患者(P = 0.030)。在男性中,高BMI组的5年RFS和CSS率高于正常BMI组(分别为P = 0.003和0.006)。多变量分析显示,在男性中,高BMI与更高的RFS或CSS率相关(风险比:RFS,0.901,P = 0.001;CSS,0.822,P < 0.001)。在女性中,根据BMI的5年RFS和CSS率无显著差异(分别为P = 0.531和0.323),高BMI与RFS或CSS无关(分别为P = 0.250和0.180)。
在nm-cRCC患者中,肥胖对男性患者是一个有利的预后因素,对女性患者则不然。因此,肥胖与nm-cRCC预后之间的关联可能因性别而异。